• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[联合内分泌治疗后出现鳞状分化的前列腺癌:一例报告]

[Prostate carcinoma with squamous differentiation after combination endocrine therapy: a case report].

作者信息

Nagashima Takao, Niiro Mako, Hirayama Kifu, Date Seiki, Okihara Koji, Mukaisho Ken-Ichi

机构信息

The Department of Urology, Nagahama City Kohoku Hospital.

出版信息

Hinyokika Kiyo. 2012 Aug;58(8):457-60.

PMID:23052274
Abstract

We report a case of squamous differentiated prostate carcinoma that developed after combination endocrine therapy for adenocarcinoma of the prostate. The patient was a 68-year-old man who visited our hospital with microscopic hematuria. His serum prostate-specific antigen (PSA) level was 7. 06 ng/ml. Transperineal needle biopsy was performed and histological examinations indicated moderately differentiated adenocarcinoma with a Gleason score of 4 + 4 = 8. Computed tomography showed swelling of left external iliac lymph node. The clinical stage was T3aN1M0. Six weeks after combination endocrine therapy using goserelin acetate and bicalutamide, the patient underwent radical prostatectomy and bilateral pelvic lymphadenectomy. Histopathological examination of the surgical specimen demonstrated squamous cell carcinoma of the prostate with very small areas of adenocarcinoma. The treatment measure was changed from endocrine therapy to combination chemotherapy consisting of docetaxel, cisplatin, and 5- FU. Eighteen month has passed after the surgery without any evidence of distant metastasis.

摘要

我们报告一例前列腺腺癌接受联合内分泌治疗后发生的鳞状分化前列腺癌病例。患者为一名68岁男性,因镜下血尿前来我院就诊。其血清前列腺特异性抗原(PSA)水平为7.06 ng/ml。行经会阴穿刺活检,组织学检查显示为中度分化腺癌,Gleason评分为4 + 4 = 8。计算机断层扫描显示左髂外淋巴结肿大。临床分期为T3aN1M0。在使用醋酸戈舍瑞林和比卡鲁胺进行联合内分泌治疗六周后,患者接受了根治性前列腺切除术和双侧盆腔淋巴结清扫术。手术标本的组织病理学检查显示为前列腺鳞状细胞癌,伴有非常小面积的腺癌。治疗措施从内分泌治疗改为由多西他赛、顺铂和5-氟尿嘧啶组成的联合化疗。术后已过去18个月,无远处转移迹象。

相似文献

1
[Prostate carcinoma with squamous differentiation after combination endocrine therapy: a case report].[联合内分泌治疗后出现鳞状分化的前列腺癌:一例报告]
Hinyokika Kiyo. 2012 Aug;58(8):457-60.
2
Does small-cell phenotype predict the natural history of prostate cancer? A case study in disease behavior.小细胞表型能否预测前列腺癌的自然病程?一项疾病行为的病例研究。
Nat Clin Pract Oncol. 2007 Sep;4(9):551-4. doi: 10.1038/ncponc0910.
3
Safe usage of bicalutamide and goserelin in a male patient with acute intermittent porphyria and prostate cancer.比卡鲁胺和戈舍瑞林在一名患有急性间歇性卟啉症和前列腺癌的男性患者中的安全使用。
Scand J Urol. 2019 Apr-Jun;53(2-3):171-173. doi: 10.1080/21681805.2018.1563628. Epub 2019 Feb 4.
4
Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: a case report.
Tumori. 2013 May-Jun;99(3):e120-3. doi: 10.1177/030089161309900330.
5
Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study.全雄激素阻断对前列腺癌病理分期及切除边界状态的影响。意大利PROSIT研究的初步结果。
Pathol Res Pract. 1999;195(4):201-8. doi: 10.1016/S0344-0338(99)80036-3.
6
[Successful combined treatment with maximal androgen blockade (MAB), intra arterial chemotherapy and radiation for advanced prostatic ductal adenocarcinoma : report of two cases].
Hinyokika Kiyo. 2011 Apr;57(4):209-12.
7
[A case of locally advanced prostate cancer with low serum testosterone associated with intake of an androgenic medicine].[一例与服用雄激素类药物相关的低血清睾酮水平的局部晚期前列腺癌病例]
Nihon Hinyokika Gakkai Zasshi. 2003 May;94(4):529-32. doi: 10.5980/jpnjurol1989.94.529.
8
[PRIMARY SQUAMOUS CELL CARCINOMA OF THE PROSTATE: A CASE REPORT].[前列腺原发性鳞状细胞癌:一例报告]
Nihon Hinyokika Gakkai Zasshi. 2019;110(2):129-133. doi: 10.5980/jpnjurol.110.129.
9
Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.接受睾酮灭活药物间歇性治疗的前列腺癌男性患者的前列腺癌特异性生存率和无临床进展生存率。
Urology. 2007 Sep;70(3):506-10. doi: 10.1016/j.urology.2007.04.015.
10
Chemical castration and anti-androgens induce differential gene expression in prostate cancer.化学去势和抗雄激素会导致前列腺癌中差异基因的表达。
J Pathol. 2012 Jul;227(3):336-45. doi: 10.1002/path.4027. Epub 2012 May 8.